Related Experiment Video

Updated: Jul 1, 2025

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
09:40

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

15.1K

Programmed Death Ligand 1 Regulatory Crosstalk with Ubiquitination and Deubiquitination: Implications in Cancer

Soon-Bin Kim1, Soonjae Hwang2, Ji-Young Cha1,2

  • 1Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon 21999, Republic of Korea.

International Journal of Molecular Sciences
|March 13, 2024
PubMed

Insights

Programmed death ligand 1 (PD-L1) stability is controlled by ubiquitination and deubiquitination. Targeting these processes could enhance cancer immunotherapy effectiveness.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • Programmed death ligand 1 (PD-L1) is a key mediator of cancer immune evasion.
  • PD-L1 is a critical target for cancer immunotherapy, particularly PD-1/PD-L1 blockade therapies.
  • The stability and function of PD-L1 are tightly regulated by post-translational modifications.

Purpose of the Study:

  • To review the regulatory mechanisms of PD-L1 stability and function through ubiquitination and deubiquitination.
  • To explore the roles of E3 ubiquitin ligases and deubiquitinating enzymes (DUBs) in modulating PD-L1 expression.
  • To discuss the therapeutic implications of targeting these regulatory pathways for enhanced cancer immunotherapy.

Main Methods:

  • Comprehensive literature review of studies investigating PD-L1 ubiquitination and deubiquitination.
  • Analysis of the mechanisms employed by specific E3 ubiquitin ligases in PD-L1 degradation.
  • Examination of DUBs' roles in stabilizing PD-L1 by reversing ubiquitination.

Main Results:

  • Ubiquitination by specific E3 ligases targets PD-L1 for proteasomal degradation, reducing its levels.
  • Deubiquitinating enzymes (DUBs) counteract ubiquitination, stabilizing PD-L1 and potentially promoting immune evasion.
  • The dynamic interplay between ubiquitination and deubiquitination significantly influences PD-L1 expression levels and tumor microenvironment.

Conclusions:

  • The intricate balance of ubiquitination and deubiquitination is crucial for PD-L1 regulation in cancer.
  • Targeting E3 ligases or DUBs offers novel strategies to modulate PD-L1 and improve immunotherapy outcomes.
  • Understanding these regulatory networks is vital for optimizing PD-L1/PD-1-based cancer treatments.
Keywords:
PD-L1PTMdeubiquitinationimmunotherapyubiquitination

More Related Videos

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones11:36

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones

Published on: July 25, 2019

10.7K
Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia05:24

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia

Published on: February 21, 2021

4.2K

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K